Uncategorized
New breakthrough in HIV/Aids treatment
Desmond Chingarande ·
Scientists attending the 10th International Aids Society conference on HIV Science yesterday availed a new and more efficient drug and novel remedy regimens in anti-retro-viral therapy that have potential to change the treatment of the deadly disease.
The evidence released yesterday presented the safety and efficiency of moving from three to two drug regimens therapy for people starting treatment for the first time and for people who switch after being virally suppressed on another regimen.
Addressing the media, IAS President and IAS 2019 International Scientific chair Anton Pozniak said the treatment regimens have the potential to improve long
term tolerability and reduce costs and pill sizes.
This story is for NewsDay subscribers.